BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 22, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for April 13, 2020

April 13, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, Aslan, Bausch Health, Kolon, Lilly, Nextcure, Prolynx.
Read More

Financings for April 13, 2020

April 13, 2020
Biopharmas raising money in public or private financings, including: Karolinska, Scynexis, Sol-Gel, Stealth.
Read More

Appointments and advancements for April 13, 2020

April 13, 2020
New hires and promotions in the biopharma industry, including: Avid Bioservices.
Read More

Regulatory actions for April 10, 2020

April 10, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Marker Therapeutics, Steris, Terumo.
Read More

Other news to note for April 10, 2020

April 10, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x Genomics, 3M, Biocept, Biocorrx, Care Access Research, Ceros, CIUSSS NIM, CHUM, ÉTS, Foxo Bioscience, Illumina, Lumeris, Masimo, Savantx, Van Andel Institute.
Read More

Appointments and advancements for April 10, 2020

April 10, 2020
New hires and promotions in the med-tech industry, including: Genetron, Grail.
Read More

Regulatory actions for April 10, 2020

April 10, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arrowhead, Astellas, Seneca.
Read More

Other news to note for April 10, 2020

April 10, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biogen, Immunomic, Epivax, Pharmazz, Pharmajet, Samsung Biologics, Vir, Wuxi Biologics.
Read More

In the clinic for April 10, 2020

April 10, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Company List: Astrazeneca, Biocryst, Cyclerion.
Read More

Appointments and advancements for April 10, 2020

April 10, 2020
New hires and promotions in the biopharma industry, including: Adaptive, Pantheryx, Retrophin.
Read More
Previous 1 2 … 1571 1572 1573 1574 1575 1576 1577 1578 1579 … 1721 1722 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 22, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 22, 2025.
  • Rubber duck dressed up as a doctor

    In 2025, science’s biggest story was political

    BioWorld
    In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
  • Abstract blue human heart with red cardio pulse line and red circle

    FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM

    BioWorld
    Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
  • Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis

    BioWorld Science
    Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing